US Broker Ratings

Vertex Pharmaceuticals (VRTX) Stock Analysis: Insights into a Biotech Powerhouse with a 13% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading player in the biotechnology sector, continues to capture investor attention with its strong market presence and promising drug pipeline. With a market capitalization..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Powerhouse with 78.25% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is capturing the attention of investors with its substantial market capitalization of $8.22 billion and promising drug development..

Ascendis Pharma A/S (ASND) Stock Analysis: Uncovering a 38% Upside Potential

For investors with an eye on the biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling case, with a potential upside of 38.34% according to recent analyst ratings. This..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 14.22% Potential Upside in the Healthcare Sector

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out as a compelling investment opportunity within the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of..

STERIS plc (STE) Stock Analysis: Navigating a 7.3% Potential Upside in the Healthcare Sector

For investors seeking exposure to the healthcare sector, STERIS plc (STE), a leading player in the medical devices industry, presents an intriguing opportunity. With its diverse portfolio of infection prevention..

Zimmer Biomet Holdings (ZBH): Analyst Consensus and Growth Potential Signal a 17.85% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. Headquartered in Warsaw, Indiana, this company has a rich..

BridgeBio Pharma, Inc. (BBIO) Investor Outlook: Exploring a 71.61% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing the attention of investors with its strategic focus on developing innovative therapies for genetic diseases and cancer. The company, headquartered in Palo Alto,..

Repligen Corporation (RGEN): Investor Outlook Reveals 55% Upside Potential Amid Bioprocessing Growth

Repligen Corporation (NASDAQ: RGEN), a prominent name in the healthcare sector, particularly within the medical instruments and supplies industry, presents an intriguing investment opportunity. With a market cap of $6.63..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Healthcare with a 2.77% Dividend Yield

Fresenius Medical Care AG (NYSE: FMS) stands as a pivotal player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bad Homburg, Germany, the company specializes..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a $39.71 Billion Biotech Powerhouse

As investors keenly navigate the healthcare sector, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) emerges as a noteworthy player with a market capitalization of $39.71 billion. This biotechnology firm, headquartered in Cambridge,..

Agilent Technologies, Inc. (A): Investor Outlook with a 22.94% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, specializes in diagnostics and research, offering a broad array of application-focused solutions. As investors look for viable opportunities..

Viatris Inc. (VTRS) Stock Analysis: Navigating a Challenging Landscape with a 31.81% Potential Upside

Viatris Inc. (VTRS), a prominent player in the healthcare sector, has been navigating a turbulent landscape characterized by a series of financial challenges and opportunities. As a key entity in..

Natera, Inc. (NTRA) Stock Analysis: Strong Buy Ratings and a 21.67% Potential Upside for Investors

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector specializing in diagnostics and research, is catching the attention of investors with its cutting-edge molecular testing services. Headquartered in..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 24.47% Potential Upside with a Robust Dividend Yield

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to capture investor attention as it navigates a challenging market environment. At its current price of $23.49, Pfizer offers..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating Growth with a $45.58 Billion Market Cap and Promising 16.7% Revenue Upsurge

Veeva Systems Inc. (NYSE: VEEV) continues to solidify its position as a leading provider of cloud-based software for the life sciences industry, boasting a formidable market capitalization of $45.58 billion...

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech Player with a 49.71% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the attention of investors in the biotechnology sector with its promising pipeline of cancer therapies and a significant market cap of $5.36 billion. Headquartered..

Chemed Corp (CHE) Stock Analysis: What a 17.83% Potential Upside Means for Investors

Chemed Corporation (NYSE: CHE), a notable player in the healthcare sector, specializes in offering hospice and palliative care services through its significant VITAS segment, as well as plumbing and related..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Its Robust ROE and Growth Potential

Medpace Holdings, Inc. (NASDAQ: MEDP), a key player in the healthcare sector, presents a compelling opportunity for investors focused on diagnostics and research. With its market capitalization standing at an..

Glaukos Corporation (GKOS) Investor Outlook: Analyzing the 29.88% Potential Upside Amidst Healthcare Innovation

For investors keen on the medical device sector, Glaukos Corporation (NYSE: GKOS) is a name that demands attention. As a leader in ophthalmic pharmaceuticals and medical technology, Glaukos’s innovative approach..

Revolution Medicines, Inc. (RVMD)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds